FRIDAY, Aug. 7, 2026 — The U.S. Food and Drug Administration (FDA) has approved the first flu vaccine built on messenger RNA (mRNA) technology, months after the agency refused to even consider the application.
The shot, called mFLUSIVA, is…
Blog
Leave a Reply